Abstract
Insulin receptors have been previously identified in Schistosoma japonicum that can bind human insulin. We used the purified recombined protein of the ligand domain of S.japonicum insulin receptor 2 (SjLD2) in three independent murine vaccine/challenge trials. Compared with controls, vaccination of mice with SjLD2 resulted in a significant reduction in faecal eggs, the stunting of adult worms and a reduction in liver granuloma density in all three trials. Furthermore, in the final trial, in which mature intestinal eggs were also quantified, there was a reduction in their number. These results suggest that development of a vaccine based on rSjLD2 for preventing transmission of zoonotic schistosomiasis is feasible.
Original language | English |
---|---|
Pages (from-to) | 801-807 |
Number of pages | 7 |
Journal | International Journal for Parasitology |
Volume | 42 |
Issue number | 9 |
DOIs | |
Publication status | Published - 01 Aug 2012 |
Externally published | Yes |
Keywords
- Insulin receptor
- Ligand domain
- Schistosomajaponicum
- Transmission blocking veterinary vaccine
ASJC Scopus subject areas
- Parasitology
- Infectious Diseases